Skip to main content

Pesquisar

Reset all filters
281 Result(s)
Ordenar por

Doenças Metabólicas

Doenças Metabólicas

Metabolic Diseases About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases
Tratamentos

Tratamentos

We provide a disciplined scientific approach to the global discovery, development and delivery of therapeutics for all relevant animal species.
Foco na ciência

Foco na ciência

Discover where Boehringer Ingelheim's scientific research efforts and investment is currently focused on including CNS diseases, Retinal Health & COVID-19.
EHNA

EHNA

Learn more about the metabolic disease known as non-alcoholic steatohepatitis (NASH) by clicking here and visiting Boehringer Ingelheim.
Ruminantes

Ruminantes

Our ruminants business focuses on parasiticides, vaccines and therapeutics which are offered to our dairy and beef veterinarians and farmers.
Perfil empresarial

Perfil empresarial

Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim.
Doenças Cardiovasculares

Doenças Cardiovasculares

Note: This webpage hosts content for general public as well as for healthcare professional and journalists & media professionals.
Mais ambientalismo: pelo nosso planeta

Mais ambientalismo: pelo nosso planeta

At Boehringer Ingelheim, “Sustainable Development – For Generations” is about a journey. One that started in 1885 and one that we hope, and believe
Hipertensão

Hipertensão

Effective treatment and management of hypertension are important in order to avoid further complications or risks like heart attack or stroke.
A nossa responsabilidade

A nossa responsabilidade

One of the most important elements at Boehringer Ingelheim is our responsibility to protecting the connection between human, animal and environmental health.
Cancro do Pulmão

Cancro do Pulmão

Boehringer Ingelheim provides innovative lung cancer treatments with specialist products for 1st and 2nd line non-small-cell lung cancer (NSCLC)
Acidente vascular cerebral isquémico agudo

Acidente vascular cerebral isquémico agudo

Boehringer Ingelheim developed the only licensed blood clot dissolving treatment (thrombolytic) for acute ischaemic stroke therapy, now used worldwide.
Histórias da ciência

Histórias da ciência

Desenvolver novos e melhores medicamentos para os doentes é o cerne do que fazemos. Eles inspiram-nos na nossa missão de criar tratamentos inovadores que mudam vidas, a liderar a ciência e a nunca desistir.
Foco no Doente

Foco no Doente

Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives.
Checklist de bem-estar

Checklist de bem-estar

Sonha em fugir? Com o entusiasmo de fazer as malas, itens essenciais como medicamentos e exames de saúde podem facilmente ser negligenciados.
Suínos

Suínos

A Boehringer Ingelheim é um parceiro e promotor de produção sustentável de carne de porco e proteína animal, assegurando o bem-estar animal através da prevenção e cuidados de saúde integrados.